BRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments

Reuters03-27

BRIEF-Mink <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says Co Discussing Potential Combination Trials & Strategic Minority Investments

March 27 (Reuters) - Mink Therapeutics Inc INKT.O:

MINK THERAPEUTICS INC - IN DISCUSSIONS FOR POTENTIAL COMBINATION TRIALS AND STRATEGIC MINORITY INVESTMENTS - SEC FILING
MINK THERAPEUTICS: IN DISCUSSIONS WITH MULTIPLE PARTIES REGARDING POTENTIAL COMBINATION TRIALS INVOLVING AGENT-797
MINK THERAPEUTICS INC - HAS NOT PUBLICLY DISCLOSED ANY BINDING ARRANGEMENTS FOR COMBINATION TRIALS OR STRATEGIC INVESTMENTS - SEC FILING

Source text: [ID:n0001193125-26-127931]

Further company coverage: INKT.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622875137?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 23:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622875137","market":"fut","top_or_hot":-1,"title":"BRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Mink <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says Co Discussing Potential Combination Trials &amp; Strategic Minority Investments </title></head><body><p><span>March 27 (Reuters)</span><span> - </span>Mink Therapeutics Inc <span>INKT.O</span>:</p><ul><li><p>MINK THERAPEUTICS INC - IN DISCUSSIONS FOR POTENTIAL COMBINATION TRIALS AND STRATEGIC MINORITY INVESTMENTS - SEC FILING</p></li><li><p>MINK THERAPEUTICS: IN DISCUSSIONS WITH MULTIPLE PARTIES REGARDING POTENTIAL COMBINATION TRIALS INVOLVING AGENT-797</p></li><li><p>MINK THERAPEUTICS INC - HAS NOT PUBLICLY DISCLOSED ANY BINDING ARRANGEMENTS FOR COMBINATION TRIALS OR STRATEGIC INVESTMENTS - SEC FILING</p></li></ul><p>Source text: [ID:n0001193125-26-127931]</p><p>Further company coverage: <span>INKT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 23:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Mink <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Says Co Discussing Potential Combination Trials &amp; Strategic Minority Investments </title></head><body><p><span>March 27 (Reuters)</span><span> - </span>Mink Therapeutics Inc <span>INKT.O</span>:</p><ul><li><p>MINK THERAPEUTICS INC - IN DISCUSSIONS FOR POTENTIAL COMBINATION TRIALS AND STRATEGIC MINORITY INVESTMENTS - SEC FILING</p></li><li><p>MINK THERAPEUTICS: IN DISCUSSIONS WITH MULTIPLE PARTIES REGARDING POTENTIAL COMBINATION TRIALS INVOLVING AGENT-797</p></li><li><p>MINK THERAPEUTICS INC - HAS NOT PUBLICLY DISCLOSED ANY BINDING ARRANGEMENTS FOR COMBINATION TRIALS OR STRATEGIC INVESTMENTS - SEC FILING</p></li></ul><p>Source text: [ID:n0001193125-26-127931]</p><p>Further company coverage: <span>INKT.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INKT","symbol_name":"MiNK Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0SJ:1","article_id":"2622875137","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622875137","pubTimestamp":1774625289,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments March 27  - Mink Therapeutics Inc INKT.O:MINK THERAPEUTICS INC - IN DISCUSSIONS FOR POTENTIAL COMBINATION TRIALS AND STRATEGIC MINORITY INVESTMENTS - SEC FILINGMINK THERAPEUTICS: IN DISCUSSIONS WITH MULTIPLE PARTIES REGARDING POTENTIAL COMBINATION TRIALS INVOLVING AGENT-797MINK THERAPEUTICS INC - HAS NOT PUBLICLY DISCLOSED ANY BINDING ARRANGEMENTS FOR COMBINATION TRIALS OR STRATEGIC INVESTMENTS - SEC FILINGSource text: [ID:n0001193125-26-127931]Further company coverage: INKT.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INKT":"MiNK Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"简介-Mink Therapeutics表示公司正在讨论潜在的联合试验和战略性少数股权投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INKT":0.9},"content_text":"BRIEF-Mink Therapeutics Says Co Discussing Potential Combination Trials & Strategic Minority Investments March 27 (Reuters) - Mink Therapeutics Inc INKT.O:MINK THERAPEUTICS INC - IN DISCUSSIONS FOR POTENTIAL COMBINATION TRIALS AND STRATEGIC MINORITY INVESTMENTS - SEC FILINGMINK THERAPEUTICS: IN DISCUSSIONS WITH MULTIPLE PARTIES REGARDING POTENTIAL COMBINATION TRIALS INVOLVING AGENT-797MINK THERAPEUTICS INC - HAS NOT PUBLICLY DISCLOSED ANY BINDING ARRANGEMENTS FOR COMBINATION TRIALS OR STRATEGIC INVESTMENTS - SEC FILINGSource text: [ID:n0001193125-26-127931]Further company coverage: INKT.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622875137","isCrawlerRequest":true}